The negotiating power of buyers and providers had dramatically increased, declining physician access is restricting the accountability of care organizations and increasingly stringent regulatory measures mean selling and marketing healthcare products has never been more difficult than it is today. This is just the tip of the iceberg. In such a fast-moving industry, stakeholders are being forced to deploy a various classes of new technique to maintain a competitive benefit. Some are embracing smaller drug launches to diversify and reduce sales attrition risks, while others are focusing on understanding patient needs and treatment providers’ expectations better, to reduce drug failures. We can use analytics for Clinical data integration, drug development, Sales and Marketing, statistical analysis, clinical research, reporting, forecasting, Data Mining.